We also evaluated the ratio of CD4/CD8 in peripheral blood from AL patients and healthy control, and it was significantly higher in AML-ND (p = 0.0124) and AML-CR (p = 0.0124) groups than control (Fig. 1C). Here, CD8A is linked to acute myeloid leukemia.